Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-03-01

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The healthcare systems are under increasing pressure due to a rise in emergency consultations, staff shortages, an ageing population and rising costs. Emergency departments are seeing more vulnerable patients, including elderly people, who are often on multiple medications and at risk of medication errors.

To improve safety, the integration of pharmacists specialising in emergency medicine has proven beneficial: their presence in the team improves the detection of medication-related problems, speeds up and optimises treatment, reduces rehospitalisations and lowers healthcare costs. However, in most countries, these pharmacists are still rarely found in emergency departments, mainly due to a lack of resources and clinical prioritisation criteria tailored for them and adapted to this environment.

Frailty screening tools and scores, such as ISAR, can be used to identify the elderly patients most at risk, predict adverse events such as fall or mortality, and thus adapt their care in the emergency department. Indeed, elderly frail patients often take many medications and consequently are at risk of medication errors, adverse events, inappropriate prescriptions or serious drug interactions. These patients may therefore require a specialised review on their medication by clinical pharmacists when they are admitted to the emergency department, but their high number make it impossible to care for all of them.

We aim thus to evaluate the association between frailty (according to the ISAR score) and medication-related problems among elderly patients admitted to the emergency department. Researchers will examine whether this score can predict the presence of inappropriate prescribing and high-risk drug interactions. If so, pharmacists would then have a quick and easy tool to prioritise patients who would benefit most from a specialised review of their medications when they visit the emergency department.

There will not be any intervention and this study will not influence patients care. Once patients agree to participate, researchers will prospectively collect medical data from elderly patients admitted to the emergency department and analyse their medical history, home medication, reason for admission, frailty score using ISAR, and perform a pharmaceutical analysis based on these data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy

NCT03686943

Elderly Iatrogenic Drug Risk

WITHDRAWN

The Effect of Medication Review in High-risk Emergency Department Patients

NCT02122965

Adverse Drug Events Adverse Drug Reactions Medication-related Problems

COMPLETED NA

Incidence of Iatrogenic Diseases on Hospital's Emergency Consultations

NCT03960398

Iatrogenic Disease

COMPLETED

Serious Adverse Drug Reaction and Their Preventability

NCT02888834

Adverse Drug Reaction

COMPLETED

Adverse Drug Reactions in Older Subjects

NCT03623542

Dementia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty Emergency Department Visit Elderly Drug Drug Interaction Inappropriate Drug Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elderly patients in the ED

Patients aged of 75 or more who are admitted to the emergency department

Pharmaceutical analysis based on the Electronic Patient Record

Intervention Type OTHER

After inclusion, each patient's data will be collected and analysed by the investigator in the following 5 days. The said data will be:

* Independent variables (demographic data, laboratory results, comorbidities, home medication treatment, reason for admission)
* The ISAR score, using the electronic patients record
* The number of inappropriate prescriptions, using STOPP/START version 3 online tool.
* The number of high-risk drug interactions (categories D "Consider therapy modification" and X "Avoid combination"), using Lexicomp™ Interact online tool.
* The number of drug-related problems, using the PCNE classification version 9.1, including usual home patient's treatment as well as treatment received in the ED.
* The likelihood of a medication-related emergency consultation, using AT-HARM 10 score.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharmaceutical analysis based on the Electronic Patient Record

After inclusion, each patient's data will be collected and analysed by the investigator in the following 5 days. The said data will be:

* Independent variables (demographic data, laboratory results, comorbidities, home medication treatment, reason for admission)
* The ISAR score, using the electronic patients record
* The number of inappropriate prescriptions, using STOPP/START version 3 online tool.
* The number of high-risk drug interactions (categories D "Consider therapy modification" and X "Avoid combination"), using Lexicomp™ Interact online tool.
* The number of drug-related problems, using the PCNE classification version 9.1, including usual home patient's treatment as well as treatment received in the ED.
* The likelihood of a medication-related emergency consultation, using AT-HARM 10 score.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged ≥ 75 years admitted to the adult emergency department
* Patients able to give informed consent as documented by signature or a therapeutic representative, if applicable .

Exclusion Criteria

* Patients initially admitted to the emergency resuscitation room.
* Patients admitted to the minor accidents and emergencies room.
* Patients admitted to the stroke unit, as they just pass through the emergency department to directly proceed to the CT-scanner.
* Missing data for proper file analysis (e.g., missing usual home medication)
* Patient's inability to sign consent and no therapeutic representative available
* Patient's refusal to sign consent
* Emergency physician's refusal to include patient for any reason.

Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No